Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence

Biomarkers for the lung cancer diagnosis and their advances in proteomics

(2011) Hye-Jin Sung et al.   BMB Reports

Enolase-1 as a plasminogen receptor

(2009) E. F. Plow et al.   BLOOD

Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans

(2009) Chia-Geun Chen et al.   FUNGAL GENETICS AND BIOLOGY

In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms

(2009) Marisa H. Miceli et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Synthetic glycopeptide vaccines combining  -mannan and peptide epitopes induce protection against candidiasis

(2008) H. Xin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells

(2008) Yun-Liang Yang et al.